Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq of HCC1428 LTED breast cancer cell line post ligand treatment

ABSTRACT: RNA-seq of HCC1428 LTED breast cancer cell line post ligand treatment

PROVIDER: PRJNA644983 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR12180211.fastq.gz	Fastqsanger.gz
	SRR12180212.fastq.gz	Fastqsanger.gz
	SRR12180213.fastq.gz	Fastqsanger.gz
	SRR12180214.fastq.gz	Fastqsanger.gz
	SRR12180215.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 78

Similar Datasets

RNA-seq of HCC1428 LTED breast cancer cell line post ligand treatment

Project description:Global gene expression analysis of HCC1428-LTED (long term estrogen deprived) breast cancer cell lines was evaluated after overnight treatment with 6 selective estrogen receptor degarders (SERDs). Two gene expression signatures were identified. GDC-0810 and AZD9496 have a similar gene expression profile which is distinct from fulvestrant. SAR439859 gene expression signature clusters closely with fulvestrant. Replacing the carboxylic side chain of GDC-0810 and AZD9496 with a basic side chain of SAR439859 to make novel SERDs, GDC-SAR and AZD-SAR, respectively, shifts the gene expression signature to more closely align to that of fulvestrant. The effect of SERDs on gene expression can be used to further differentiate classes of SERDs.

2020-07-10 | GSE154058 | GEO

RNA-seq of breast cancer cell lines post ligand treatment II

Project description:RNA-seq of breast cancer cell lines post ligand treatment II

| PRJNA529360 | ENA

RNA-seq of breast cancer cell lines post ligand treatment I

Project description:RNA-seq of breast cancer cell lines post ligand treatment I

| PRJNA483773 | ENA

RNA-seq of breast cancer cell lines post ligand treatment II

Project description:Goal: study the impact of estrogen receptor ligands on gene expression in HR+ breast cancer cells Methods: RNA sequencing Results: Ligand 4-OH tamoxifen, a selective ER modulator (SERM), promotes transcriptional activation of ER and mimics the transcriptional effect of natural ligand E2 for a subset of ER target genes, consistently across the seven breast cell lines (MDA-MB-134 VI, MDA-MB-330, EFM-19, T-47D, and BT-474). Selective ER degraders (SERD) fulvestrant and GDC-0927 on the other hand do not induce, or induce very weakly the expression of ER target genes. The effect of GDC-0810 depends on the cellular context.

2019-07-25 | GSE128911 | GEO

RNA-seq of breast cancer cell lines post ligand treatment I

Project description:Goal: study the impact of estrogen receptor ligands on gene expression in HR+ breast cancer cells Methods: RNA sequencing Results: Ligand 4-OH tamoxifen, a selective ER modulator (SERM), promotes transcriptional activation of ER and mimics the transcriptional effect of natural ligand E2 for a subset of ER target genes, consistently across the seven breast cell lines (MCF-7, HCC1500, MDA-MB-330, EFM-19, T-47D, BT-474, and CAMA-1). Selective ER degraders (SERD) fulvestrant and GDC-0927 on the other hand do not induce, or induce very weakly the expression of ER target genes. The effect of GDC-0810 depends on the cellular context.

2019-07-25 | GSE117942 | GEO

ATAC-seq of MCF-7 cells post ligand treatment

Project description:ATAC-seq of MCF-7 cells post ligand treatment

| PRJNA483774 | ENA

ATAC-seq, ChIP-seq and RNA-seq of breast cancer cell lines post ligand treatment

Project description:ATAC-seq, ChIP-seq and RNA-seq of breast cancer cell lines post ligand treatment

| PRJNA483771 | ENA

ATAC-seq of MCF-7 cells post ligand treatment

Project description:Goal: study the impact of estrogen receptor ligands on chromatin accessibility in MCF-7 cells Methods: Assay for Transposase-Accessible Chromatin using Sequencing (ATAC-Seq) Results: Ligand 4-OH tamoxifen, a selective ER modulator (SERM), significantly alters chromatin accessibility and partially mimics the effect of natural ligand E2 on chromatin accessibility in MCF-7 breast cells. Selective ER degraders (SERD) fulvestrant and GDC-0927 on the other hand have very little impact on chromatin accessibility.

2019-07-25 | GSE117940 | GEO

Molecular Determinants of Post-Mastectomy Breast Cancer Recurrence

Project description:Molecular Determinants of Post-Mastectomy Breast Cancer Recurrence

2018-09-20 | PRJEB28702 | EVA

ChIP-seq of ER in MCF-7 cells post ligand treatment

Project description:ChIP-seq of ER in MCF-7 cells post ligand treatment

| PRJNA483772 | ENA